arrow
Back
H

Hossein Borghaei

department of medical oncology

64H-index
515Paper Count
3.0WCitation Count
Published Papers 120
Publication Date
The impact of EGFR subtype combined with TP53 co-mutation status on survival outcomes with front-line osimertinib in non-small cell lung cancer (NSCLC)
err2026-08-14
err0
PREAI
errHye Sung Kim; Li Zhang; J.Nicholas Bodor; Margie L. Clapper; Hossein Borghaei; Martin J. Edelman; Yunyun Zhou; Mitchell Cheung; Joseph Treat
errShare
errSave
Mitochondrial ACSS1 links acetate metabolism to pyrimidine biosynthesis in nutrient-stressed B-cell lymphomas
err2026-04-07
err0
errOAAI
errJohnvesly Basappa; Aaron R. Goldman; Cosimo Lobello; Shengchun Wang; David Rushmore; Olga Melnikov; Neil V. Sen; Vinay S. Mallikarjuna; Priyanka Jain; Masoud Edalati; David S. Nelson; Kathy Q. Cai; Pin Lu; Reza Nejati; Hossein Borghaei; Pradeep K. Gupta; Kavindra Nath; Kathryn E. Wellen; Mariusz A. Wasik
errShare
errSave
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities
errCancer
IF5.1
err2026-02-28
err0
errOAAI
errSonam Puri MD; Andrew Elliott PhD; Abdul Rafeh Naqash MD; Hassan Abu Shukair MD; Kathleen C. Kerrigan DO; Shiven Patel MD; Andreas Seeber MD, PhD; Florian Kocher PhD; Dipesh Uprety MD; Hirva Mamdani MD; Amit A. Kulkarni MD; Gilberto Lopes MD; Balazs Halmos MD; Hossein Borghaei DO; Wallace Akerley MD; Gabriel L. Sica MD, PhD; Stephen V. Liu MD; Trudy G. Oliver PhD; Taofeek K. Owonikoko MD, PhD
errShare
errSave
Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology in patients with advanced non-small-cell lung cancer (FRACTION-Lung)
err2026-02-16
err0
errOAAI
errK. He; P.M. Forde; R. Govindan; A. Santoro; S. Gettinger; H. Borghaei; A. Spira; Q. Chu; R. Zinner; A.J. Schoenfeld; D.R. Camidge; D.R. Spigel; A. Gurpide; R.A. Juergens; S.A. Laurie; M. Cerra; T. Spires; D.M. Greenawalt; I. Rapoport; J.F. Gainor
errShare
errSave
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma
err2025-08-19
err0
errOAAI
errAmin H. Nassar; Chul Kim; Tolulope Adeyelu; Elias Bou Farhat; Hassan Abushukair; Mehrdad Rakaee; Kelsey Matteson; Shun-Fat Lau; Yamato Takabe; Antonio Ocejo; Fatemeh Ardeshir-Larijani; Ticiana Leal; Suresh Ramalingam; Sumaiya Alam; Jhanelle E. Gray; James Hicks; David Kaldas; Javier Baena; Maria Zurera Berjaga; Frank Aboubakar Nana; Christian Grohe; Heike Leuders; Fabrizio Citarella; Alessio Cortellini; Emanuele Claudio Mingo; Danny Pancirer; Millie Das; Timothy John Ellis-Caleo; Justin M. Cheung; Jessica J. Lin; Alexander S. Watson; D. Ross Camidge; Arthi Sridhar; Kaushal Parikh; Fionnuala Crowley; Thomas U. Marron; Vanya Aggarwal; Murtaza Ahmed; Kamya Sankar; Hassan Kawtharany; Jun Zhang; Dwight H. Owen; Mingjia Li; Misako Nagasaka; David J. Pinato; Nichola Awosika; Khaled Alhamad; Sonam Puri; Unaiza Zaman; Divya M. Gupta; Chelsea Lau; Hina Khan; Justin Liauw; Ana I. Velazquez; Tyiesha Brown; Laura Moliner; Miguel Mosteiro; Pedro Rocha; Mark Evans; Ari Vanderwalde; Andrew Elliott; Jorge Nieva; Gilberto Lopes; Patrick C. Ma; Hossein Borghaei; Matthew Lee; Lauren Young; Raid Aljumaily; Haris Mirza; David J. Kwiatkowski; Roy S. Herbst; Richard A. Flavell; Abdul Rafeh Naqash; Anne C. Chiang
errShare
errSave
Treatment-Free Survival Over 6 Years of Follow-up in Patients With Metastatic NSCLC Treated With First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 227 Part 1
err2025-06-03
err0
PREAI
errSolange Peters; Meredith M. Regan; Luis G. Paz-Ares; Martin Reck; Hossein Borghaei; Kenneth J. O’Byrne; Julie R. Brahmer; John R. Penrod; Janice Li; LaRee Tracy; Yong Yuan; Judith Bushong; Adam Lee; Laura J. Eccles; Saurabh Ray; Suresh S. Ramalingam
errShare
errSave
Prevalence and molecular correlates of acquired EGFR resistance mutations in non-small cell lung cancer (NSCLC)
err2025-04-17
err0
PREAI
errRaez, Luis E.; Baca, Yasmine; Ribeiro, Jennifer R.; Nieva, Jorge J.; Mamdani, Hirva; Lopes, Gilberto; Borghaei, Hossein; Socinski, Mark; Wozniak, Antoinette J.; Vanderwalde, Ari; Uribe, Carlos Carracedo; Sumarriva, Daniel; Khan, Hina; Liu, Stephen V.; Nagasaka, Misako
errShare
errSave
Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial
err2025-03-01
err0
errOAAI
errHummel, Horst-Dieter; Ahn, Myung-Ju; Blackhall, Fiona; Reck, Martin; Akamatsu, Hiroaki; Ramalingam, Suresh S.; Borghaei, Hossein; Johnson, Melissa; Dirnberger, Franziska; Cocks, Kim; Huang, Shuang; Mukherjee, Sujoy; Paz-Ares, Luis
errShare
errSave
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer
errCANCER
IF5.1
err2025-01-28
err0
errOAAI
errSands, Jacob M.; Champiat, Stephane; Hummel, Horst-Dieter; Paulson, Kelly G.; Borghaei, Hossein; Alvarez, Jean Bustamante; Carbone, David P.; Carlisle, Jennifer W.; Choudhury, Noura J.; Clarke, Jeffrey M.; Gadgeel, Shirish M.; Izumi, Hiroki; Navarro, Alejandro; Lau, Sally C. M.; Lammers, Philip E.; Huang, Shuang; Hamidi, Ali; Mukherjee, Sujoy; Owonikoko, Taofeek K.
errShare
errSave
Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
err2025-01-01
err0
errOAAI
errSun, Lova; Zhou, Yunyun; Handorf, Elizabeth A.; Borghaei, Hossein; Bauman, Jessica; Aggarwal, Charu
errShare
errSave
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activation
err2024-12-01
err0
PREAI
errHsiehchen, David; Elliott, Andrew; Xiu, Joanne; Seeber, Andreas; El-Deiry, Wafik; Antonarakis, Emmanuel S.; Graff, Stephanie L.; Hall, Michael J.; Borghaei, Hossein; Hoon, Dave S. B.; V. Liu, Stephen; Ma, Patrick C.; Mckay, Rana R.; Wise-Draper, Trisha; Marshall, John; Sledge, George W.; Spetzler, David; Zhu, Hao
errShare
errSave
Plain language summary: tarlatamab for patients with previously treated small cell lung cancer
err2024-11-12
err0
errOAAI
errAhn, Myung-Ju; Cho, Byoung Chul; Felip, Enriqueta; Korantzis, Ippokratis; Ohashi, Kadoaki; Majem, Margarita; Juan-Vidal, Oscar; Handzhiev, Sabin; Izumi, Hiroki; Lee, Jong-Seok; Dziadziuszko, Rafal; Wolf, Juergen; Blackhall, Fiona; Reck, Martin; Alvarez, Jean Bustamante; Hummel, Horst-Dieter; Dingemans, Anne-Marie C.; Sands, Jacob; Akamatsu, Hiroaki; Owonikoko, Taofeek K.; Ramalingam, Suresh S.; Borghaei, Hossein; Johnson, Melissa L.; Huang, Shuang; Mukherjee, Sujoy; Minocha, Mukul; Jiang, Tony; Martinez, Pablo; Anderson, Erik S.; Paz-Ares, Luis
errShare
errSave
Clinical outcomes in Black patients with EGFR-mutated NSCLC treated with osimertinib
err2024-09-21
err0
PREAI
errBelani, Neel; Rizwan, Farsha; Hasler, Jill; Bauman, Jessica; Mitchell, Khadijah; Borghaei, Hossein; Bodor, Joseph N.
errShare
errSave
A genomic scar based signature (HRDsig) and biallelic BRCA alterations identify a homologous recombination deficiency (HRD) phenotype of non-small cell lung cancer (NSCLC) potentially actionable to the PARP inhibitor rucaparib: Post-hoc analysis of lung-MAP substudy S1900A
err2024-09-01
err0
PREAI
errRiess, J. W.; Miao, J.; Wheatley-Price, P.; Reckamp, K. L.; Kozono, D.; Redman, M. W.; Edelman, M. J.; Faller, B.; Villaruz, L.; Corum, L.; Gowda, A.; Srkalovic, G.; Osarogiagbon, R.; Baumgart, M.; Gandara, D. R.; Sokol, E. S.; Borghaei, H.; Gray, J. E.; Herbst, R. S.; Kelly, K.
errShare
errSave
Cancer treatments as paradoxical catalysts of tumor awakening in the lung
err2024-07-04
err1
errOAAI
errNicolas, Emmanuelle; Kosmider, Beata; Cukierman, Edna; Borghaei, Hossein; Golemis, Erica A.; Borriello, Lucia
errShare
errSave
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers
err2024-03-25
err2
PREAI
errMuquith, Maishara; Espinoza, Magdalena; Elliott, Andrew; Xiu, Joanne; Seeber, Andreas; El-Deiry, Wafik; Antonarakis, Emmanuel S.; Graff, Stephanie L.; Hall, Michael J.; Borghaei, Hossein; Hoon, Dave S. B.; Liu, Stephen V.; Ma, Patrick C.; McKay, Rana R.; Wise-Draper, Trisha; Marshall, John; Sledge, George W.; Spetzler, David; Zhu, Hao; Hsiehchen, David
errShare
errSave
Tissue- specific thresholds and microenvironment correlates of tumor mutation burden associated with immunotherapy benefit and prognosis in microsatellite stable cancers
err2024-03-22
err0
PREAI
errMuquith, Maishara; Espinoza, Magdalena; Elliott, Andrew; Xiu, Joanne; Seeber, Andreas; El-Deiry, Wafik; Antonarakis, Emmanuel S.; Graff, Stephanie; Hall, Michael J.; Borghaei, Hossein; Hoon, Dave S.; Liu, Stephen V.; Ma, Patrick C.; McKay, Rana R.; Wise-Draper, Trisha; Marshall, John; Sledge, George W.; Spetzler, David; Zhu, Hao; Hsieh, David
errShare
errSave
A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors
err2024-02-01
err3
errOAAI
errBeckermann, Kathryn E.; Bestvina, Christine M.; El Osta, Badi; Sanborn, Rachel E.; Borghaei, Hossein; Lammers, Philip Edward; Selvaggi, Giovanni; Whisenant, Jennifer G.; Heimann-Nichols, Ellen; Berry, Lynne; Hsu, Chih-Yuan; Shyr, Yu; Horn, Leora; Wakelee, Heather
errShare
errSave
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
err2024-01-01
err20
PREAI
errBorghaei, H.; de Marinis, F.; Dumoulin, D.; Reynolds, C.; Theelen, W. S. M. E.; Percent, I.; Calderon, V. Gutierrez; Johnson, M. L.; Madroszyk-Flandin, A.; Garon, E. B.; He, K.; Planchard, D.; Reck, M.; Popat, S.; Herbst, R. S.; Leal, T. A.; Shazer, R. L.; Yan, X.; Harrigan, R.; Peters, S.
errShare
errSave